Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


12.06.2017

1 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
2 Ann Neurol
1 Biol Psychiatry
3 Brain
1 Dement Geriatr Cogn Disord
13 J Alzheimers Dis
5 J Biol Chem
1 J Clin Psychiatry
1 J Clin Psychopharmacol
1 JAMA
1 Nervenarzt
3 Neurobiol Aging
1 Neurochem Res
2 Neurology
1 PLoS Med
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. STONNINGTON CM, Harel B, Locke DEC, Hentz JG, et al
    Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Jun 2. doi: 10.1097/WAD.0000000000000200.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  2. TOLPPANEN AM, Taipale H, Hartikainen S
    Head or brain injuries and Alzheimer's disease: A nested case-control register study.
    Alzheimers Dement. 2017 Jun 6. pii: S1552-5260(17)30201.
    PubMed     Text format     Abstract available


    Ann Neurol

  3. BAYKARA E, Gesierich B, Adam R, Tuladhar AM, et al
    A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms.
    Ann Neurol. 2016 Aug 12. doi: 10.1002/ana.24758.
    PubMed     Text format     Abstract available

  4. TIRABOSCHI P, Corso A, Guerra UP, Nobili F, et al
    123 I-FP-CIT SPECT and 123 I-MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from other dementias: a comparative study.
    Ann Neurol. 2016 Jul 11. doi: 10.1002/ana.24717.
    PubMed     Text format     Abstract available


    Biol Psychiatry

  5. GOIRAN T, Duplan E, Chami M, Bourgeois A, et al
    beta-Amyloid Precursor Protein Intracellular Domain Controls Mitochondrial Function by Modulating Phosphatase and Tensin Homolog-Induced Kinase 1 Transcription in Cells and in Alzheimer Mice Models.
    Biol Psychiatry. 2017 May 3. pii: S0006-3223(17)31515.
    PubMed     Text format     Abstract available


    Brain

  6. GEORGE C, Gontier G, Lacube P, Francois JC, et al
    The Alzheimer's disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons.
    Brain. 2017 Jun 8. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. CAPSONI S, Malerba F, Carucci NM, Rizzi C, et al
    The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor.
    Brain. 2017;140.
    PubMed     Text format     Abstract available

  8. AHMED RM, Landin-Romero R, Collet TH, van der Klaauw AA, et al
    Energy expenditure in frontotemporal dementia: a behavioural and imaging study.
    Brain. 2017;140.
    PubMed     Text format     Abstract available


    Dement Geriatr Cogn Disord

  9. RAMIREZ-GOMEZ L, Zheng L, Reed B, Kramer J, et al
    Neuropsychological Profiles Differentiate Alzheimer Disease from Subcortical Ischemic Vascular Dementia in an Autopsy-Defined Cohort.
    Dement Geriatr Cogn Disord. 2017;44.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  10. CANSEV M, Turkyilmaz M, Sijben JWC, Sevinc C, et al
    Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 9. doi: 10.3233/JAD-170081.
    PubMed     Text format     Abstract available

  11. WILKINS HM, Mahnken JD, Welch P, Bothwell R, et al
    A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.
    J Alzheimers Dis. 2017 Jun 7. doi: 10.3233/JAD-170077.
    PubMed     Text format     Abstract available

  12. ANAND S, Barnes JM, Young SA, Garcia DM, et al
    Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.
    J Alzheimers Dis. 2017 Jun 9. doi: 10.3233/JAD-170035.
    PubMed     Text format     Abstract available

  13. GONZALEZ-MACIEL A, Reynoso-Robles R, Torres-Jardon R, Mukherjee PS, et al
    Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-170012.
    PubMed     Text format     Abstract available

  14. NAGAI M, Dote K, Kato M, Sasaki S, et al
    Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks.
    J Alzheimers Dis. 2017 Jun 7. doi: 10.3233/JAD-161172.
    PubMed     Text format     Abstract available

  15. DILLEN KNH, Jacobs HIL, Kukolja J, Richter N, et al
    Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-161120.
    PubMed     Text format     Abstract available

  16. ANDREADOU E, Pantazaki AA, Daniilidou M, Tsolaki M, et al
    Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-161020.
    PubMed     Text format     Abstract available

  17. FERGUSON SA, Panos JJ, Sloper D, Varma V, et al
    Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-170204.
    PubMed     Text format     Abstract available

  18. LUPTON MK, Benyamin B, Proitsi P, Nyholt DR, et al
    No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-170027.
    PubMed     Text format     Abstract available

  19. LIN FV, Wang X, Wu R, Rebok GW, et al
    Identification of Successful Cognitive Aging in the Alzheimer's Disease Neuroimaging Initiative Study.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-161278.
    PubMed     Text format     Abstract available

  20. BINOSHA FWMAD, Somaratne G, Williams S, Goozee KG, et al
    Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention?
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-161200.
    PubMed     Text format     Abstract available

  21. ADEGOKE OO, Qiao F, Liu Y, Longley K, et al
    Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-beta Accumulation in Mice.
    J Alzheimers Dis. 2017 Jun 8. doi: 10.3233/JAD-170173.
    PubMed     Text format     Abstract available

  22. YU Q, Du F, Douglas JT, Yu H, et al
    Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2017 Jun 6. doi: 10.3233/JAD-170283.
    PubMed     Text format     Abstract available


    J Biol Chem

  23. YOSHIMURA Y, Holmberg MA, Kukic P, Andersen CB, et al
    MOAG-4 promotes the aggregation of alpha-synuclein by competing with self-protective electrostatic interactions.
    J Biol Chem. 2017;292:8269-8278.
    PubMed     Text format     Abstract available

  24. SEIXAS DA SILVA GS, Melo HM, Lourenco MV, Lyra E Silva NM, et al
    Amyloid-beta oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons.
    J Biol Chem. 2017;292:7395-7406.
    PubMed     Text format     Abstract available

  25. BRITO-MOREIRA J, Lourenco MV, Oliveira MM, Ribeiro FC, et al
    Interaction of amyloid-beta (Abeta) oligomers with neurexin 2alpha and neuroligin 1 mediates synapse damage and memory loss in mice.
    J Biol Chem. 2017;292:7327-7337.
    PubMed     Text format     Abstract available

  26. KORSHAVN KJ, Satriano C, Lin Y, Zhang R, et al
    Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-beta.
    J Biol Chem. 2017;292:4638-4650.
    PubMed     Text format     Abstract available

  27. BODE DC, Baker MD, Viles JH
    Ion Channel Formation by Amyloid-beta42 Oligomers but Not Amyloid-beta40 in Cellular Membranes.
    J Biol Chem. 2017;292:1404-1413.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  28. LIPEROTI R, Sganga F, Landi F, Topinkova E, et al
    Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment.
    J Clin Psychiatry. 2017;78:e76-e82.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  29. LEE C, Lee K, Yu H, Ryu SH, et al
    Adverse Events With Sustained-Release Donepezil in Alzheimer Disease: Relation to Body Mass Index.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000726.
    PubMed     Text format     Abstract available


    JAMA

  30. GOTTESMAN RF, Schneider AL, Zhou Y, Coresh J, et al
    Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
    JAMA. 2017;317:1443-1450.
    PubMed     Text format     Abstract available


    Nervenarzt

  31. KARACA I, Wagner H, Ramirez A
    [Search for risk genes in Alzheimer's disease].
    Nervenarzt. 2017 Jun 2. doi: 10.1007/s00115-017-0354.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  32. HOENIG MC, Bischof GN, Hammes J, Faber J, et al
    Tau pathology and cognitive reserve in Alzheimer's disease.
    Neurobiol Aging. 2017;57:1-7.
    PubMed     Text format     Abstract available

  33. SLATTERY CF, Zhang J, Paterson RW, Foulkes AJM, et al
    ApoE influences regional white-matter axonal density loss in Alzheimer's disease.
    Neurobiol Aging. 2017;57:8-17.
    PubMed     Text format     Abstract available

  34. COLEMAN PD, Mastroeni D
    A call for new approaches to Alzheimer's disease research.
    Neurobiol Aging. 2017 May 10. pii: S0197-4580(17)30157.
    PubMed     Text format    


    Neurochem Res

  35. TWYMAN RE
    Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion.
    Neurochem Res. 2017 Jun 7. doi: 10.1007/s11064-017-2300.
    PubMed     Text format     Abstract available


    Neurology

  36. BUCKLEY RF, Schultz AP, Hedden T, Papp KV, et al
    Functional network integrity presages cognitive decline in preclinical Alzheimer disease.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004059.
    PubMed     Text format     Abstract available

  37. CHEN J, Yu JT, Wojta K, Wang HF, et al
    Genome-wide association study identifies MAPT locus influencing human plasma tau levels.
    Neurology. 2017;88:669-676.
    PubMed     Text format     Abstract available


    PLoS Med

  38. WHITE CC, Yang HS, Yu L, Chibnik LB, et al
    Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data.
    PLoS Med. 2017;14:e1002287.
    PubMed     Text format     Abstract available


    PLoS One

  39. LEE SE, Hyun H, Park MR, Choi Y, et al
    Production of transgenic pig as an Alzheimer's disease model using a multi-cistronic vector system.
    PLoS One. 2017;12:e0177933.
    PubMed     Text format     Abstract available

  40. KAZEMIFAR S, Manning KY, Rajakumar N, Gomez FA, et al
    Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease.
    PLoS One. 2017;12:e0178529.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: